Literature DB >> 35928197

The role of wirelessly observed therapy in improving treatment adherence.

Kartik Kumar1, Michael R Loebinger2, Saira Ghafur3.   

Abstract

Wirelessly observed therapy (WOT) offers a novel way of monitoring treatment adherence. In this article, we provide an overview of how this technology works and discuss the evidence for its clinical effectiveness in tuberculosis, hepatitis C virus infection, mental health and cardiovascular disease. We consider the acceptability of WOT to patients as well as potential issues relating to patient autonomy and data protection. We highlight the current limited data on its economic impact and reflect on its future role in patient care. © Royal College of Physicians 2022 All rights reserved.

Entities:  

Keywords:  digital health; health policy; ingestible sensors; tuberculosis; wirelessly observed therapy

Year:  2022        PMID： 35928197      PMCID： PMC9345231          DOI： 10.7861/fhj.2021-0165

Source DB:  PubMed          Journal:  Future Healthc J        ISSN： 2514-6645


  22 in total

1.  Promoting adherence to treatment for tuberculosis: the importance of direct observation.

Authors:  Thomas R Frieden; John A Sbarbaro
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

2.  Digital drug fortunes falter.

Authors: 
Journal:  Nat Biotechnol       Date:  2020-02       Impact factor: 54.908

3.  Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tuberculosis treatment.

Authors:  K Y Au-Yeung; L DiCarlo
Journal:  Int J Tuberc Lung Dis       Date:  2012-09-18       Impact factor: 2.373

4.  First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.

Authors:  John M Kane; Roy H Perlis; Lorenzo A DiCarlo; Kityee Au-Yeung; Jessie Duong; Georgios Petrides
Journal:  J Clin Psychiatry       Date:  2013-06       Impact factor: 4.384

5.  Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.

Authors:  Timothy Peters-Strickland; Linda Pestreich; Ainslie Hatch; Shashank Rohatagi; Ross A Baker; John P Docherty; Lada Markovtsova; Praveen Raja; Peter J Weiden; David P Walling
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-11       Impact factor: 2.570

6.  Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co-encapsulation.

Authors:  S H Browne; C Peloquin; F Santillo; R Haubrich; L Muttera; K Moser; G M Savage; C A Benson; T F Blaschke
Journal:  Clin Pharmacol Ther       Date:  2017-09-19       Impact factor: 6.875

7.  Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study.

Authors:  Kristina M Brooks; Jose R Castillo-Mancilla; Mary Morrow; Samantha MaWhinney; Sarah E Rowan; David Wyles; Joshua Blum; Ryan Huntley; Lana M Salah; Arya Tehrani; Lane R Bushman; Peter L Anderson; Jennifer J Kiser
Journal:  Open Forum Infect Dis       Date:  2020-11-19       Impact factor: 4.423

8.  Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy.

Authors:  Robert Belknap; Steve Weis; Andrew Brookens; Kit Yee Au-Yeung; Greg Moon; Lorenzo DiCarlo; Randall Reves
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

9.  Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.

Authors:  Sara H Browne; Anya Umlauf; Amanda J Tucker; Julie Low; Kathleen Moser; Jonathan Gonzalez Garcia; Charles A Peloquin; Terrence Blaschke; Florin Vaida; Constance A Benson
Journal:  PLoS Med       Date:  2019-10-04       Impact factor: 11.069

Review 10.  Acceptability of digital health interventions: embracing the complexity.

Authors:  Olga Perski; Camille E Short
Journal:  Transl Behav Med       Date:  2021-07-29       Impact factor: 3.046
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.